{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T16:50:59Z","timestamp":1775494259359,"version":"3.50.1"},"reference-count":23,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2022,1,6]],"date-time":"2022-01-06T00:00:00Z","timestamp":1641427200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cells"],"abstract":"<jats:p>The cause of multiple myeloma (MM) remains largely unknown. Several pieces of evidence support the involvement of genetic and multiple environmental factors (i.e., chemical agents) in MM onset. The inter-individual variability in the bioactivation, detoxification, and clearance of chemical carcinogens such as asbestos, benzene, and pesticides might increase the MM risk. This inter-individual variability can be explained by the presence of polymorphic variants in absorption, distribution, metabolism, and excretion (ADME) genes. Despite the high relevance of this issue, few studies have focused on the inter-individual variability in ADME genes in MM risk. To identify new MM susceptibility loci, we performed an extended candidate gene approach by comparing high-throughput genotyping data of 1936 markers in 231 ADME genes on 64 MM patients and 59 controls from the CEU population. Differences in genotype and allele frequencies were validated using an internal control group of 35 non-cancer samples from the same geographic area as the patient group. We detected an association between MM risk and ADH1B rs1229984 (OR = 3.78; 95% CI, 1.18\u201312.13; p = 0.0282), PPARD rs6937483 (OR = 3.27; 95% CI, 1.01\u201310.56; p = 0.0479), SLC28A1 rs8187737 (OR = 11.33; 95% CI, 1.43\u201389.59; p = 0.005), SLC28A2 rs1060896 (OR = 6.58; 95% CI, 1.42\u201330.43; p = 0.0072), SLC29A1 rs8187630 (OR = 3.27; 95% CI, 1.01\u201310.56; p = 0.0479), and ALDH3A2 rs72547554 (OR = 2.46; 95% CI, 0.64\u20139.40; p = 0.0293). The prognostic value of these genes in MM was investigated in two public datasets showing that shorter overall survival was associated with low expression of ADH1B and SLC28A1. In conclusion, our proof-of-concept findings provide novel insights into the genetic bases of MM susceptibility.<\/jats:p>","DOI":"10.3390\/cells11020189","type":"journal-article","created":{"date-parts":[[2022,1,7]],"date-time":"2022-01-07T01:15:26Z","timestamp":1641518126000},"page":"189","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Risk Alleles for Multiple Myeloma Susceptibility in ADME Genes"],"prefix":"10.3390","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8149-7957","authenticated-orcid":false,"given":"Francesca","family":"Scionti","sequence":"first","affiliation":[{"name":"Institute of Research and Biomedical Innovation (IRIB), Italian National Council (CNR), 98164 Messina, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Agapito","sequence":"additional","affiliation":[{"name":"Department of Law, Economics and Sociology, Magna Graecia University of Catanzaro, 88100 Catanzaro, Italy"},{"name":"Data Analytics Research Center, Magna Graecia University of Catanzaro, 88100 Catanzaro, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniele","family":"Caracciolo","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, Magna Graecia University, 88100 Catanzaro, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Riillo","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, Magna Graecia University, 88100 Catanzaro, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0268-5536","authenticated-orcid":false,"given":"Katia","family":"Grillone","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, Magna Graecia University, 88100 Catanzaro, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1502-2387","authenticated-orcid":false,"given":"Mario","family":"Cannataro","sequence":"additional","affiliation":[{"name":"Data Analytics Research Center, Magna Graecia University of Catanzaro, 88100 Catanzaro, Italy"},{"name":"Department of Medical and Surgical Sciences, Magna Graecia University of Catanzaro, 88100 Catanzaro, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8205-2706","authenticated-orcid":false,"given":"Maria Teresa","family":"Di Martino","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, Magna Graecia University, 88100 Catanzaro, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierosandro","family":"Tagliaferri","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, Magna Graecia University, 88100 Catanzaro, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8298-6787","authenticated-orcid":false,"given":"Pierfrancesco","family":"Tassone","sequence":"additional","affiliation":[{"name":"Department of Experimental and Clinical Medicine, Magna Graecia University, 88100 Catanzaro, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariamena","family":"Arbitrio","sequence":"additional","affiliation":[{"name":"Institute of Research and Biomedical Innovation (IRIB), Italian National Council (CNR), 88100 Catanzaro, Italy"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2022,1,6]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"757","DOI":"10.2174\/156800912802429300","article-title":"Molecular Targets for the Treatment of Multiple Myeloma","volume":"12","author":"Rossi","year":"2012","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3707","DOI":"10.1038\/s41467-018-04989-w","article-title":"Identification of multiple risk loci and regulatory mechanisms influencing susceptibility to multiple myeloma","volume":"9","author":"Went","year":"2018","journal-title":"Nat. Commun."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/s41375-019-0703-6","article-title":"Genetic predisposition for multiple myeloma","volume":"34","author":"Pertesi","year":"2020","journal-title":"Leukemia"},{"key":"ref_4","first-page":"6386","article-title":"Pesticide Exposure and Risk of Monoclonal Gammopathy of Undetermined Significance (Mgus) in the Agricultural Health Study","volume":"113","author":"Landgren","year":"2009","journal-title":"Am. J. Epidemiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.2217\/pgs.15.141","article-title":"The role of ADME pharmacogenomics in early clinical trials: Perspective of the Industry Pharmacogenomics Working Group (I-PWG)","volume":"16","author":"Tremaine","year":"2015","journal-title":"Pharmacogenomics"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/cts.12869","article-title":"Pharmacogenomics Biomarker Discovery and Validation for Translation in Clinical Practice","volume":"14","author":"Arbitrio","year":"2021","journal-title":"Cts-Clin. Transl. Sci."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/leu.2011.352","article-title":"Polymorphisms in xenobiotic transporters ABCB1, ABCG2, ABCC2, ABCC1, ABCC3 and multiple myeloma risk: A case-control study in the context of the International Multiple Myeloma rESEarch (IMMEnSE) consortium","volume":"26","author":"Martino","year":"2012","journal-title":"Leukemia"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.3389\/fonc.2019.01056","article-title":"The Association of GSTT1, GSTM1, and TNF-alpha Polymorphisms With the Risk and Outcome in Multiple Myeloma","volume":"9","author":"Zmorzynski","year":"2019","journal-title":"Front. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-2141.2011.08622.x","article-title":"A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: Analysis by DMET microarray profiling","volume":"154","author":"Arbitrio","year":"2011","journal-title":"Brit. J. Haematol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s00280-015-2916-3","article-title":"Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysis","volume":"77","author":"Arbitrio","year":"2016","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/cpt.1391","article-title":"Polymorphic Variants in NR1I3 and UGT2B7 Predict Taxane Neurotoxicity and Have Prognostic Relevance in Patients With Breast Cancer: A Case-Control Study","volume":"106","author":"Arbitrio","year":"2019","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"107558","DOI":"10.18632\/oncotarget.22505","article-title":"Genetic variants associated with Fabry disease progression despite enzyme replacement therapy","volume":"8","author":"Scionti","year":"2017","journal-title":"Oncotarget"},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"85895","DOI":"10.18632\/oncotarget.13135","article-title":"Genetic variants associated with gastrointestinal symptoms in Fabry disease","volume":"7","author":"Scionti","year":"2016","journal-title":"Oncotarget"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"3177","DOI":"10.1182\/blood-2006-09-044974","article-title":"Gene expression profiling and correlation with outcome in clinical trials of the proteasome inhibitor bortezomib","volume":"109","author":"Mulligan","year":"2007","journal-title":"Blood"},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Guzzi, P.H., Agapito, G., Di Martino, M.T., Arbitrio, M., Tassone, P., Tagliaferri, P., and Cannataro, M. (2012). DMET-Analyzer: Automatic analysis of Affymetrix DMET Data. BMC Bioinform., 13.","DOI":"10.1186\/1471-2105-13-258"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"4377","DOI":"10.1093\/bioinformatics\/btaa529","article-title":"BioPAX-Parser: Parsing and enrichment analysis of BioPAX pathways","volume":"36","author":"Agapito","year":"2020","journal-title":"Bioinformatics"},{"key":"ref_17","doi-asserted-by":"crossref","unstructured":"Agapito, G., and Cannataro, M. (2021). Using BioPAX-Parser (BiP) to enrich lists of genes or proteins with pathway data. BMC Bioinform., 22.","DOI":"10.1186\/s12859-021-04297-z"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Hu, D.G., Mackenzie, P.I., Nair, P.C., McKinnon, R.A., and Meech, R. (2020). The Expression Profiles of ADME Genes in Human Cancers and Their Associations with Clinical Outcomes. Cancers, 12.","DOI":"10.3390\/cancers12113369"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"BSR20181915","DOI":"10.1042\/BSR20181915","article-title":"Association of ADH1B Arg47His polymorphism with the risk of cancer: A meta-analysis","volume":"39","author":"Tan","year":"2019","journal-title":"Biosci. Rep."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1007\/s00280-013-2246-2","article-title":"The association between the expression of solute carrier transporters and the prognosis of pancreatic cancer","volume":"72","author":"Brynychova","year":"2013","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"4274","DOI":"10.1038\/s41467-019-12131-7","article-title":"Discovering genetic interactions bridging pathways in genome-wide association studies","volume":"10","author":"Fang","year":"2019","journal-title":"Nat. Commun."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Yin, Z.H., Wu, D.J., Shi, J.P., Wei, X.Y., Jin, N.Y., Lu, X.L., and Ren, X.H. (2020). Identification of ALDH3A2 as a novel prognostic biomarker in gastric adenocarcinoma using integrated bioinformatics analysis. BMC Cancer, 20.","DOI":"10.1186\/s12885-020-07493-x"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Gallo Cantafio, M.E., Grillone, K., Caracciolo, D., Scionti, F., Arbitrio, M., Barbieri, V., Pensabene, L., Guzzi, P.H., and Di Martino, M.T. (2018). From Single Level Analysis to Multi-Omics Integrative Approaches: A Powerful Strategy towards the Precision Oncology. High Throughput, 7.","DOI":"10.3390\/ht7040033"}],"container-title":["Cells"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/2\/189\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:00:34Z","timestamp":1760364034000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2073-4409\/11\/2\/189"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,6]]},"references-count":23,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2022,1]]}},"alternative-id":["cells11020189"],"URL":"https:\/\/doi.org\/10.3390\/cells11020189","relation":{},"ISSN":["2073-4409"],"issn-type":[{"value":"2073-4409","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,6]]}}}